The effects of dietary cholesterol and oxidized cholesterol on mammary tumor development were examined in female Sprague-Dawley rats exposed to the carcinogen yV-methyl-N-nitrosourea (MNU). Animals were administered 50 mg/kg MNU at 50 days of age and fed either a control (AIN-76) diet or the control diet supplemented with 03% cholesterol or 03% oxidized cholesterol for up to 26 weeks. The oxidized cholesterol was prepared by heating cholesterol at 110°C for 48 h. Gas chromatographic analysis of the oxidized cholesterol revealed a 2% yield of oxidation products in addition to a large amount of unchanged cholesterol (>96%). Tumor incidence in the cholesterol group (67%) was significantly lower than in the control group (96%, P <0.05), but the oxidized cholesterol group (79%) was not significantly different from the control or cholesterol groups. Average number of tumors per animal was lower in the cholesterol group (IS) than in the control (2.8) or oxidized cholesterol groups (23, P < 0.005). Serum low density lipoprotein (LDL) cholesterol was greater in the cholesterol (185 ± 38 mg/dl) and the oxidized cholesterol groups (160 ± 34 mg/dl) than in the controls (55 ± 4 mg/ dJ, P <0.05), although there was no difference between the cholesterol and the oxidized cholesterol groups. These results show that dietary cholesterol inhibits mammary tumor development in this model. Elevated serum LDL cholesterol may inhibit de novo cholesterol synthesis in preneoplastic and/or tumor cells, thereby inhibiting their proliferation.
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Cholesterol is known to oxidize readily in air, giving rise to a variety of products (1), many of which have been detected in foods such as processed meats and dairy products (2) . Some products of cholesterol oxidation are known to be cytotoxic, mutagenic, immunosupressive and carcinogenic (3-6). Petrakis et al. (7) detected cholesterol a-and P-epoxides in nipple aspirate fluid of women with benign breast disease. In a subsequent study (8) the levels of cholesterol fj-epoxide were found to be higher in nulliparous women than in those who were lactating, parous or had previously breast fed. It was postulated that the lower risk of breast cancer in women who have had a full-term pregnancy may be related to the lower exposure of their duclal epithelial cells to cholesterol epoxide. Furthermore, Wrensch et al. (9) found higher than normal levels of cholesterol fj-epoxide in breast fluid aspirates of women with benign breast disease, with or without atypical hyperplasia of the epithelium. They postulated that this may be a factor in the increased incidence of breast cancer associated with hyperplasia.
In spite of this circumstantial evidence suggesting that cholesterol oxidation may be involved in breast cancer development, its role in experimental mammary carcinogenesis has not been explored. Thus to determine whether cholesterol oxidation products promote rat mammary adenocarcinogenesis we prepared oxidized cholesterol by the method of Kendall et al. (10) , who showed that their product enhances the development of preneoplastic lesions in the murine colon. Cholesterol (5-[6]-cholesten-3-ol) was purchased from Sigma Chemical Co. (St Louis, MO) and stored in a dark sealed container at -20°C to prevent oxidation. To prepare oxidized cholesterol, cholesterol was spread evenly to a thickness of 5 mm on the surface of a glass tray and heated at 110°C for 48 h in an electric oven. Analyses of cholesterol and oxidized cholesterol were performed on a Varian 3400 gas chromatograph with a flame ionization detector. Cholesterol, 5a-cholestane, 7-ketocholesterol, 3P,5a,6p-cholestanetriol, 7P-hydroxycholesterol and cholesterol 5a,6a-epoxide, purchased from Sigma Chemical Co. (St Louis, MO), were analyzed as their trimethylsilyl ether derivatives on a fused silica capillary SE-30 column (0.25 mmX30 m; Altech, Guelph, Canada) with a liquid phase thickness of 0.25 |im. 5a-Cholestane was used as an internal standard. Samples were injected at a column temperature of 270°C that was raised to 300°C at a rate of 10°C7min. The injector and detector temperatures were 275 and 320°C respectively. Nitrogen was used as the carrier gas with a flow rate of 0.4 ml/min. All samples and standards were analyzed in triplicate. Gas chromatographic analysis showed that the purity of the cholesterol was >98%, while the oxidized cholesterol contained -2% oxidation products and 96% unchanged cholesterol. The major oxidation products were 3p,5a,6P-cholestanetriol, 7p-hydroxycholesterol, 7-ketocholesterol and cholesterol 5a,6a-epoxide, as assessed by comparison of retention times with those of authentic standards. There were also a few minor unidentified peaks.
We added the oxidized cholesterol to the diets of female rats that had been administered yV-methyl-N-nitrosourea (MNU*), an agent known to be an efficient initiator of mammary adenocarcinogenesis (II). Since we showed that cholesterol oxidized by this procedure contains a large amount of unchanged cholesterol, we also fed a group of animals a diet containing cholesterol that had not been oxidized. The control AIN-76 diet consisted of 50% sucrose, 20% casein, 15% starch, 5% alphacel, 5% corn oil, 3.5% mineral mix, 1% AIN-76 vitamin mix, 0.3% DL-methionine and 0.2% choline. To the control diet was added 0.3% cholesterol or 0.3% oxidized cholesterol at the expense of sucrose, levels that had previously been shown to enhance colonic preneoplasia (10). The same batches of cholesterol and oxidized cholesterol were used throughout the experiment. The diets were prepared weekly and stored in dark plastic bags at -20°C. Fresh diet was added to the cages three times per week.
Pathogen-free female Sprague-Dawley rats (43 days old) purchased from Charles River Laboratories (St Constant, Quebec, Canada) were housed at 24 ± 2°C at 50% humidity with a 12 h light/dark cycle. They were acclimatized for 7 days before the start of die experiment with food and water provided ad libitum. At 50 days of age the animals received an i.p. injection of 50 mg/kg MNU (Sigma Chemical Co., St Louis, MO) dissolved in 0.05% acetic acid in normal saline and used within 30 min of preparation. Three days after carcinogen administration the rats were randomized into the three dietary groups (24/group). They were weighed biweekly and palpable lesions were recorded weekly. Moribund animals, those widi tumors >15 mm, or those remaining after 26 weeks were anesthetized, blood samples were taken by cardiac puncture and then the animals were sacrificed by cervical dislocation. Tumors were excised, fixed in 10% buffered formalin, embedded in paraffin, sectioned and stained with hematoxylin and eosin for histopathological examination. Serum prepared from the blood samples was stored at -70°C prior to analysis for total, low density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol (Vita Tech Laboratories, Toronto, Canada). Tumor incidence data were analyzed by x 2 analysis of variance. The average number of tumors per animal and serum cholesterol values were compared using analysis of variance followed by Student's Mest.
The final body weights of the animals in the three groups did not differ (data not shown). The cumulative tumor incidences for the three groups of animals are shown in Figure 1 . All tumors were shown to be adenocarcinomas by histopathological examination. The final tumor incidence in the cholesterol-fed group was significantly lower than the control (67 versus 96%, P <0.05). The tumor incidence in the animals fed oxidized cholesterol (79%) did not differ Weeks after MNU 160 significantly from the control or cholesterol groups. The average number of tumors per animal is shown in Figure 2 . As was the case for tumor incidence, animals in the cholesterol group had fewer tumors (1.5) than in the control (2.8) or the oxidized cholesterol groups (2.3, P <0.005). Two animals in the cholesterol group had tumors that regressed then subsequently reappeared. The number of tumors per tumor-bearing rat did not differ significantly between groups; the means (ranges) were control 2.9 (1-8), cholesterol 2.3 (1-8) and oxidized cholesterol 2.9 (1-10). Table I shows the serum cholesterol values for the three dietary groups. Total serum cholesterol was significantly greater in both the cholesterol and the oxidized cholesterol groups than the control group (P <0.01). LDL cholesterol levels in the cholesterol and oxidized cholesterol groups were significantly greater than in the control group (P <0.05). However, both LDL cholesterol and total cholesterol did not differ between the groups fed cholesterol and the oxidized cholesterol. HDL cholesterol was lower in the oxidized cholesterol group than in the control and cholesterol groups (P <0.05).
In these experiments, designed to examine the effects of oxidized cholesterol on the promotion of MNU-induced rat mammary tumors, we first showed that oxidation of cholesterol by the method of Kendall et al. (10) gave a product that contained only -2% oxidation products, the remainder being unchanged cholesterol. It was, therefore, necessary to monitor the effects of unoxidized cholesterol in the diets of an additional
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Oxidized Cholesterol Cholesterol Fig. 2 . The average number of tumors per animal in groups fed control, 0.3% oxidized cholesterol or 0.3% cholesterol diets. Groups not sharing the same letter differ significantly (P <0.005). Mammary tumorigenests inhibition by cholesterol group of animals. Unexpectedly, we found that this group fed a diet containing 0.3% cholesterol had a significantly lower incidence of tumors and a smaller number of tumors per animal than animals fed the control diet containing no cholesterol.
In previous studies Klurfeld and Kritchevsky (12) fed cholesterol plus bile salts to Sprague-Dawley rats initiated with dimethylbenz[a]anthracene (DMBA). They observed a small increase in the mammary tumor yield per rat compared with controls, but tumor incidence and size were not changed. However, the effect of cholesterol in these experiments was not distinguished from that of the bile salts. Nakayama et al. (13) also showed a small, but not statistically significant, increase in mammary tumor incidence in Sprague-Dawley rats initiated with DMBA and fed 0.2% cholesterol in a diet similar to that used in the present experiment. It is not clear why these results differ from ours, but differences have been shown in the endocrine responsiveness of DMBA-and MNU-induced tumors (14) and in their patterns of oncogene activation (15, 16) .
Cohen and Chan (17) found that cholesterol at a level of 2% in the diet of Fisher rats had no effect on MNU-induced mammary tumor development, regardless of the amount of fat in the diet. Their diets, however, were higher in saturated fat and lower in unsaturated fat than in our experiments. Since animals fed saturated fat have a lower tumor incidence than those fed unsaturated fat (18) , a protective effect of cholesterol on MNU-induced mammary tumors may have been masked. Furthermore, Fisher rats are of intermediate sensitivity to chemically induced mammary tumors, having a maximum tumor incidence of-50% (19) (20) (21) . We used the highly sensitive Sprague-Dawley strain, which has a maximum tumor incidence of close to 100%, which may have enabled us to detect inhibitory effects more easily. Fisher rats also differ from Sprague-Dawley rats in their response to dietary cholesterol. Placed on the same hypercholesterolemic diet some rat strains have been demonstrated to show a marked increase in serum cholesterol (responders), while other strains show no such response (non-responders) (22) . Although serum cholesterol measurements were not made by Cohen and Chan, Fisher rats appear to be non-responders (12) . The Sprague-Dawley rats used in our experiments are responders (22) , a result confirmed by our measurements of the effect of dietary cholesterol on serum cholesterol levels ( Table I ).
The elevated serum LDL cholesterol levels in the animals fed cholesterol may be associated with the inhibition of tumorigenesis that we observed. This cholesterol can enter cells via the LDL receptor and act as a negative feedback inhibitor of endogenous cholesterol biosynthesis by reducing the level of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase (23) . This rate limiting enzyme in the cholesterol biosynthesis pathway converts HMG-CoA to mevalonate, which is required for DNA synthesis and cell proliferation (24, 25) . Thus in our model exogenous cholesterol may inhibit de novo cholesterol synthesis in preneoplastic mammary epithelial cells, thereby inhibiting their proliferation and subsequent development into neoplasms. In support of this notion we have recently shown that dietary cholesterol inhibits the development of preneoplastic lesions in the colons of mice (26) . In addition to effects on preneoplastic cells, the growth of mammary adenocarcinoma cells may also be inhibited. Although cancer cells are generally believed to lack feedback control by serum cholesterol (27) , this appears to have been demonstrated only in hepatomas and leukemia cells (28) .
Several studies have demonstrated that inhibitors of cholesterol biosynthesis, such as lovastatin and simvastatin, suppress tumor cell growth both in vitro (29, 30) and in vivo (31, 32) . This evidence provides further support that,inhibiting cholesterol biosynthesis, regardless of the mechanism, can inhibit tumor growth. Furthermore, <i-limonene, an inhibitor of cholesterol synthesis, produces a dose-dependent inhibition of DMBAinduced mammary tumors in rats (33) and is being investigated as an anticancer agent (34) . Conversely, cholestyramine, which lowers serum cholesterol levels by inhibiting reabsorption of bile acids, stimulates cholesterol biosynthesis and promotes mammary tumor growth (35) .
The rats fed oxidized cholesterol had a somewhat lower incidence of tumors than the controls and a somewhat higher incidence than those fed cholesterol, although the effects were not statistically significant. It is possible that one or more of the cholesterol oxidation products are tumor promoters that have the effect of reducing the inhibitory effect of the cholesterol to some extent. Whatever the mechanism, our results suggest that it is important in studies of the biological effects of cholesterol to minimize oxidation. Indeed, cholesterol stored at room temperature may contain significant levels of oxidation products (36) .
In summary, our studies have shown that dietary cholesterol inhibits the promotion of MNU-induced mammary tumors in Sprague-Dawley rats. The elevated LDL cholesterol in the serum of these animals may mediate this inhibition. We have also shown that cholesterol heated to produce -2% oxidation products does not inhibit tumorigenesis.
